Both in Pharmaceuticals
Ocular Therapeutix vs Phibro Animal Health
Over the past year OCUL returned −38.9% and PAHC returned −10.4%; their daily moves had a correlation of 0.09.
OCUL −38.9% PAHC −10.4%Growth of $1, one year, split-adjusted
| Metric | OCUL | PAHC |
|---|---|---|
| Price | $6.97 | $38.88 |
| Market cap | $1.53B | $1.58B |
| Today | −4.65% | +0.05% |
| 1 month | −4.4% | +8.4% |
| 6 months | −26.1% | −29.2% |
| Year to date | −42.6% | +4.1% |
| 1 year | −39.3% | −5.6% |
| Revenue growth (YoY) | +0.1% | +4.8% |
| Gross margin | 85.1% | 33.9% |
| Net margin | −584.5% | 5.5% |
| P/E (TTM) | — | 15.8× |
| Price / sales | 29.4× | 1.0× |
| Net cash | $525.8M | -$650.8M |
| Dividend yield | — | 1.23% |
| Volatility (60d) | 76.1% | 30.4% |
| Short % of float | 15.1% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).